All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

382

Reset

382 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • QEL-001HLA-A2 CAR-TregPhase 21 trial

    Quell Therapeutics Limited · Rejection; Transplant, Liver, Liver Failure, Liver Diseases

  • QL2401Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • RABI-767Phase 21 trial

    Panafina, Inc. · Acute Pancreatitis

  • Helsinn Healthcare SA · Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy

  • RO6874281Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • RP-001Phase 21 trial

    Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer

  • RR001Phase 21 trial

    EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma

  • SKB315Phase 21 trial

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Gastroesophageal Junction Adenocarcinoma

  • SL-28Phase 21 trial

    Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic

  • SNP-610Phase 21 trial

    Sinew Pharma Inc. · NASH - Nonalcoholic Steatohepatitis

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • SPH5030Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Biliary Tract or Colorectal Cancer With Her2-positive/Mutated

  • SYS6062Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)

  • Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation

  • TAK-101Phase 21 trial

    Takeda · Celiac Disease

  • TAK-242Phase 21 trial

    Yaqrit Ltd · Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic

  • TER-2013Phase 21 trial

    Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer

  • TGM-312-SC01Phase 21 trial

    Tangram Therapeutics Plc · Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • TQA2225AP025Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Non-alcoholic Steatohepatitis

  • TRYP-0082Phase 21 trial

    TRYP Therapeutics · Irritable Bowel Syndrome

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

  • vopimetostatPhase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • VSA006Phase 21 trial

    Visirna Therapeutics HK Limited · Nash

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

  • XER-001Phase 21 trial

    Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

  • Y101DPhase 21 trial

    Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma

  • YL-13027Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • ZED1227Phase 21 trial

    Dr. Falk Pharma GmbH · Celiac Disease

  • ZSP1601Phase 21 trial

    Guangdong Raynovent Biotech Co., Ltd · Nonalcoholic Steatohepatitis (NASH)

NewerPage 8 of 8

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.